Antimicrobial and Antioxidant Activities of Bauhinia racemosa Lam. and Chemical Content

authors:

avatar Khaled Rashed a , * , avatar Monica Butnariu b

Pharmacognosy Department, National Research Centre, Dokki, Giza, Egypt.
Chemistry and Vegetal Biochemistry, Banat
Iranian Journal of Pharmaceutical Research : IJPR: Vol.13, issue 3; 1073-1080
article type: Original Article
received: November , 2012
accepted: April , 2013
DOI: https://doi.org/10.22037/ijpr.2014.1556

how to cite: Rashed K, Butnariu M. Antimicrobial and Antioxidant Activities of Bauhinia racemosa Lam. and Chemical Content. Iran J Pharm Res. 2014;13(3):e125509. https://doi.org/10.22037/ijpr.2014.1556.

Abstract

Methanol 70% extract of Bauhinia racemosa aerial parts was tested for antimicrobial activity against different bacterial and fungal strains and for antioxidant activity and also total content of polyphenols with phytochemical analysis of the extract was determined. The results have showed that the extract has a significant antimicrobial activity, it inhibited the growth of Bacillus subtilis and also it was highly active against Candida albicans suggesting that it can be used in the treatment of fungal infections. The extract has a good antioxidant activity, it has shown high values of the trolox equivalent antioxidant capacity and polyphenol content while it has shown a lower value of oxygen radical absorbance capacity. Phytochemical analysis has shown that it has interesting phytochemical bioconstituents, include flavonoids, tannins and others, and the deep phytochemical study results in the isolation of methyl gallate, gallic, kaempferol, quercetin, querection 3–O–α–rhamnoside, kaempferol 3–O–β–glucoside, myricetin–3–O–β– glucoside, querection–3–O–rutinoside (Rutin). All compounds were identified by different spectroscopic analyses (UV, 1H–NMR, 13C–NMR) and Mass Spectrometry (MS).

Introduction

Infectious diseases are the world’s leading cause of premature deaths, killing almost 50 000 people every day. Infections due to a variety of bacterial etiologic agents, such as Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae are most common. With the continuous use of antibiotics, microorganisms have become resistant, in addition to these problems; antibiotics are sometimes associated with adverse effects on host which include hypersensitivity, depletion of beneficial gut, mucosal microorganism, immunosuppression and allergic reactions (1, 2) has created immense clinical problem in the treatment of infection diseases (3, 4). Therefore, there is a need to search for new potential effective biocompounds against pathogenic bacteria and fungi. There have been many stretched based studies screening programmes initiated over the precedent years, in which extensive numbers of plant species have been estimated for their antimicrobial potential (5-7). Free radicals concur from over a hundred from over a hundred disorders in humans through atherosclerosis, arthritis and ischemia, damage of many tissues, central nervous system (CNS) damage, gastritis, cancer and AIDS. Antioxidants or molecules with radical scavenging capacity are intent to execute a potential effect against free radical damage. It has been mentioned the antioxidant activity of plants might be due to their phenolic or/and flavonoid biocompounds (8, 9). Bauhinia racemosa belongs to Caesalpiniaceae Family. It occurs in India, Ceylon and China. Many uses of the plant organs in folk medicinal were reported, flowers is used as a diuretic. Flowers, buds and dried leaves are used to treat dysentery. Root bark is used in inflammation of liver (10, 11). Seeds are tonic and aphrodisiac. Leaves have antidiabetic Action (12, 13). Plant is used in snake bite and scorpion string. Chemical bioconstituents such as β–sitosterol and β–amyrin were separated from the stem bark (14, 15), besides these biocompounds, at least two flavonols (kaempferol and quercetin) and two coumarins (scopoletin and scopolin) were separated from the leaves of the plant (16). Stilbene (resveratrol) was separated from the heart wood of B. racemosa (17). General phyto–pharmacological screening of the plant have revealed that the ethanol extract of B. racemosa leaves shows analgesic, antipyretic, anti–inflammatory and antiplasmodic activities (18, 19) as well as antimicrobial activity and antihistaminic effect (20, 13). The fresh flower buds of the plant showed antiulcer activity (21), as well as hypotensive and hypothermic activity (22, 23). No previous biological and phytochemical examinations of Bauhinia racemosa aerial parts have been undertaken. The purpose of the present study was to evaluate the antimicrobial and antioxidant activities of aerial parts from the plant and also total polyphenol content with phytochemical analysis were determined.

Experimental

Material and methods

UV/VIS: Shimadzu UV-visible recording spectrophotometer model-UV 240 (NRC, Egypt). 1H-NMR spectra: Varian Unity Inova 400 (400 MHz); 13C-NMR spectra: Varian Unity 400 (100 MHz) (Graz University, Austria). MS (Finnigan MAT SSQ 7000, 70 ev). (Silica gel (0.063-0.200 mm for column chro matography) and Sephadex LH-20 (Pharmacia Fine Chemicals). Solvent mixtures, BAW (n-butanol: acetic acid: water 4:1:5 upper phase, 15% acetic acid: water: glacial acetic acid: 85:15). Paper Chromatography (PC) Whatman No.1 (Whatman Led. Maid Stone, Kent, England) sheets for qualitative detection of flavonoids and sugars.

Plant material

Aerial parts of Bauhinia racemosa were collected from Orman garden, Giza, Egypt in April 2011. The plant was identified by Dr. Mohammed El–Gebaly, Department of Botany, National Research Centre (NRC) and by Mrs. Tereez Labib Consultant of Plant Taxonomy at the Ministry of Agriculture and director of Orman botanical garden, Giza, Egypt. A voucher specimen No. 2345 is deposited in the herbarium of Orman garden, Giza, Egypt.

Prepartion of the extract

700 g of air dried powder from the aerial parts of B. racemosa was extracted with methanol 70% at room temperature several times until exhaustion. The extract was concentrated under reduced pressure to give 54 g of crude extract.

Antimicrobial assays

The quantitative assay of the antimicrobial activity was performed by broth microdilution method (24, 25) in 96–well microplates in order to establish the minimal inhibitory concentration (MIC). The antimicrobial activity was tested against Gram–positive strains (Staphylococcus aureus ATCC 29213, Bacillus subtilis ATCC), Gram–negative (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 7953, Klebsiella pneumoniae ATCC 10131) and fungal strain (Candida albicans ATCC 10231). The methanol extract of B. racemosa was tested for its antimicrobial activity using a qualitative screening assay of the antimicrobial properties by the adapted disk diffusion method, Kirby–Bauer method (26). The quantitative assay of the antimicrobial activity was performed by binary microdilution method (24), in order to establish the minimal inhibitory concentration (MIC). The antimicrobial activity of the investigated extract was tested against bacterial and fungal strains: Gram positive (Staphylococcus aureus, Bacillus subtilis), Gram–negative (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae) and fungal strains (Candida albicans). The microbial strains were identified using a VITEK I automatic system. VITEK cards for the identification and the susceptibility testing (GNS–522) were inoculated and incubated according to the manufacturer’s recommendations. In our experiments there were used bacterial suspensions of 1.5x108 UFC/ mL or 0.5 McFarland density obtained from 15–18 h bacterial cultures developed on solid media. The antimicrobial activity was tested on Mueller–Hinton medium recommended for the bacterial strains and Yeast Peptone Glucose (YPG) medium for Candida albicans. Solutions of the extract in DMSO (dimethyl sulfoxide) having 2048 μg/ mL concentration were used.

Qualitative screening of the antimicrobial properties of the extract

The antimicrobial activity of the extract was investigated by qualitative screening of the susceptibility spectrum of different microbial strains to the tested extract solubilised in DMSO (1 mg/mL) using adapted variants of the diffusion method. In the 1st variant, 10 μL of the extract solution were equally distributed on the paper filter disks placed on Petri dishes previously seeded “in layer” with the tested bacterial strain inoculums. In the 2nd variant, 10 μL of the tested extract solutions were placed in the agar wells cut in the solid culture medium seeded with the microbial inoculum. In the 3rd variant of the qualitative antimicrobial activity assay, 10 μL of the extract solutions were spotted on Petri dishes seeded with bacterial/yeast inoculum. In all the three variants, the Petri dishes were left at room temperature to ensure the equal diffusion of the compound in the medium or to allow the drop of solution to be adsorbed in the medium and afterwards the dishes were incubated at 37 °C for 24 hours. The solvent used was also tested in order to evaluate a potential antimicrobial activity.

Quantitative assay of the antimicrobial activity

For the quantitative assay of the antimicrobial activity of the extract by the microdilution method (24, 27) in liquid medium distributed in 96–well plates, binary serial dilutions of the tested extract solutions were performed. There were obtained concentrations from 1000 μg/mL to 0.97 μg/mL in a 200 μL culture medium final volume, afterwards each well was seeded with a 50 μL microbial suspension of 0.5 MacFarland density. In each test a microbial culture control (a series of wells containing exclusively culture medium with the microbial suspension) and a sterility control (a series of wells containing exclusively culture medium) were performed. The plates were incubated for 24 hours at 37 °C.

Antioxidant assays

Extraction: 0.2 g of extract with 10 mL Millipore water boiled was sonic, centrifuged and filtered. Evaluation of antioxidant activity of the extract, using methods Oxygen Radical Absorbance Capacity (ORAC), Trolox equivalent antioxidant capacity (TEAC) and determination of total polyphenols content:

Oxygen Radical Absorbance Capacity (ORAC)

This method determines peroxil radical inhibition capacity, inducing oxidation highlighting the classical radical release; H atom transfer ORAC values were reported as Trolox equivalents, is expressed as micromol TE/DW. The intensity was monitored at 485 nm and 525 nm for 35 min.

Trolox equivalent antioxidant capacity method (TEAC)

This method is based the neutralizing capacity the radical anion ABTS+ [2,2'–azino–bis (3–ethylbenzothiazoline–6–sulphonic acid)] by antioxidants. ABTS is oxidized by radicals peroxil or other oxidants to its radical cation ABTS+, intensely colored (λmax = 734 nm). Antioxidant capacity is expressed compounds tested as potential, to discoloration by direct reaction with it radical ABTS+.

The total content of polyphenols

The blue compounds formed between phenols and Folin–Ciocalteu reagent phenolic compounds are independent of structure, thus developing complex between metal center and phenolic compounds. Absorption was recorded at a wavelength of 765 nm. Total phenol content was expressed as gallic acid equivalents (28).

Qualitative phytochemical analysis

The extract was tested for the presence of bioactive compounds by using following standard tests (Molisch᾽s test for carbohydrates, Shinoda test for flavonoids, froth test for saponins, Salkowski᾽s for terpenes and sterols, FeCl3 and Mayer᾽s reagents for detecting of tannins and alkaloids, respectively (29-31).

Isolation of bioactive compounds from methanol extract of B. racemosa

The extract 54 g was defatted with n–hexane and the extract residue 42 g which was subjected to Silica gel column chromatography eluting with dichloromethane, ethyl acetate and methanol gradually. One hundred and twenty fractions were collected. The fractions that showed similar Paper Chromatography (PC) in Butanol–Acetic acid–Water 4:1:5 (BAW) and 15% acetic acid were combined to give 4 fractions (I, II, III, and IV). Fraction I (950 mg) was subjected to sub–column of silica gel eluted with dichloromethane: ethyl acetate (60:40) gave compound 1 (methyl gallate, 60 mg) and elution with dichloromethane: ethyl acetate (90:10) gave compound 2 (gallic acid, 100 mg). Fraction II (830 mg) was subjected to sub–column of silica gel eluted with dichloromethane: ethyl acetate (95:5) to give compound 3 (kaempferol, 40 mg) and elution with ethyl acetate solvent gave compound 4 (quercetin, 25 mg). Compound 5 (quercetin–3–O–α–rhamnoside, 35 mg) and 6 (kaempferol–3–O–β–glucoside, 15 mg) were obtained from elution with ethyl acetate: Methanol (90:10) from fraction III (640 mg) and their purification were carried out on sephadex LH–20 column which eluted with methanol (50%). Compound 7 (myricetin–3–O–β–glucoside, 20 mg) and 8 (quercetin–3–O–rutinoside, 60 mg) were isolated from fraction IV (1.2 g) by sub–column of silica gel eluted with ethyl acetate: methanol (60:40) and their purification were carried out on sephadex LH–20 column which eluted with methanol (50%).

Acid hydrolysis of flavonoids

Solutions of 5 mg of compounds 5, 6, 7 and 8 in 5 mL 10% HCl were heated for 5 h. The reaction mixture was extracted with Ethyl acetate. The Ethyl acetate fraction (aglycone) and the aqueous fraction (sugars) were concentrated for identification. The sugars were identified by TLC (acetonitrile–water 85:15) by comparsion with authentic samples.

Results and Discussion

The present investigation was focused to evaluate the antimicrobial activity (expressed in μg/mL) and antioxidant capacity (expressed as Trolox equivalents and total polyphenol content) as can be seen in Table 1 and Table 2. The aim of the present study was to investigate the presence of phytochemicals, estimation of the main bioactive constituents of B. racemosa aerial parts. The major bioactive components of B. racemosa are methyl gallate, gallic acid, kaempferol, quercetin, quercetin 3–O–α–rhamnoside, kaempferol 3–O–β–glucoside, myricetin 3–O–β–glucoside and quercetin 3–O–rutinoside. The structure of bioactive components was elucidated by different spectroscopic analyses.

Table 1

Results of Antimicrobial activity of B. racemosa extract expressed in μg/ mL (MIC).

Material testedK. pneumoniaeIC 13420E. coliIC 13529S. aureusIC 13204P. aeruginosaATCC 27853B. subtilATCC 6633C. albicansIC 249
B. racemosa extract62.5125250125317.8
Blank DMSO 125125250125125125

MIC =minimal inhibitory concentration.

Table 2

Results of Antioxidant capacity of B. racemosa extract tested were expressed as Trolox equivalents and total polyphenol content

Material testedTotal polyphenol content (gallic acid mg/g DW)Oxygen radical absorbance capacity (ORAC) assay valueTrolox equivalent antioxidant capacity (TEAC) assay value
B. racemosa extract695.1 ± 3.56 mg/g 1033 mM TE/g201 ± 3.6 mM TE/g
Chemical structures of Phenolic compounds isolated from B. racemosa

Chemical structures of Phenolic compounds isolated from B. racemosa

Figure 1

Structure Elucidation of the isolated compounds

Methyl gallate (1): white amorphous powder: UV λmax (MeOH): 275. 1H–NMR (DMSO–d6, 400 MHz): δ 6.94 (2H, s, H–2,6), 3.73 (3H, s,–OCH3). 13C–NMR (DMSO–d6, 100 MHz): δ 166.8 (–COO), 146 (C–3,5), 138.9 (C–4), 119.8 (C–1), 109 (C–2,6), 52 (–OCH3).

Gallic acid (2): white amorphous powder. UV λmax (MeOH): 273. 1H–NMR (DMSO–d6, 400 MHz): δ 7.15 (2H, s, H–2,6).13C–NMR (DMSO–d6, 100 MHz): δ 167.2 (–COOH), 145 (C–3,5), 137.7 (C–4), 121 (C–1), 109.1 (C–2,6).

Kaempferol (3): Yellow powder. UV λmax (MeOH): 265, 320, 366; (NaOMe): 276, 317, 406; (AlCl3): 262sh, 269, 310sh, 367; (AlCl3/HCl): 263sh, 268, 320sh, 344, 425; (NaOAc): 274, 306, 382; (NaOAc/H3BO3): 267, 368. 1H–NMR (DMSO–d6, 400 MHz): δ 8.11 (2H, d, J = 8 Hz, H–2',6'), 6.96 (2H, d, J=8 Hz, H–3',5'), 6.47 (1H, d, J = 2 Hz, H–8), 6.19 (1H, d, J = 2 Hz, H–6). EI–MS: m/z 286.

Quercetin (4): Yellow powder. UV λmax (MeOH): 255, 267, 371; (NaOMe): 270, 320, Citrus Aurantium & Labor Pain 1077

420; (AlCl3): 270, 455; (AlCl3/HCl): 264, 303sh, 315sh, 428; (NaOAc): 257, 274, 318, 383; (NaOAc/H3BO3): 259, 387. 1H–NMR (DMSO–d6, 400 MHz): δ 7.74 (1H, d, J = 8, 2 Hz, H–2'), 7.55 (1H, d, J = 2 Hz, H–6'), 6.92 (1H, d, J = 8 Hz, H–5'), 6.42 (1H, d, J = 1.2 Hz, H–8), 6.15 (1H, d, J = 1.2 Hz, H–6). EI–MS: m/z 302.

Quercetin 3–O–α–rhamnoside (5) Yellow crystals: 1H–NMR (400 MHz, DMSO–d6) δ ppm 7.26 (2H, m, H–2'/6'), 6.83 (1H, d, J=9 Hz, H–5'), 6.49 (1H,d, J=2.5 Hz, H–8),6.14(1H, d, J=2.5Hz,H–6), 5.25 (1H, br s, H–1'') 0.78 (3H, d, J=6Hz). 13C–NMR (100 MHz, DMSO–d6): δ ppm 177.42 (C–4), 167.45 (C–7), 161.40 (C–5), 157.01 (C–2), 157 (C–9), 149.19 (C–4'), 145.57 (C–3'), 134.12 (C–3), 131.97 (C–6'), 121.40 (C–1'), 115.71 (C–2'), 115.40 (C–5'), 103.10 (C–10), 101.97 (C–1''), 99.98 (C–6), 94.47 (C–8), 71.47 (C–4''), 70.94, 70.85, 70.62 (C–2'', C–5'', C–3''), 17.78 (C6'').

Kaempferol 3–O– β–glucoside (6): Yellow crystals. UV λmax (MeOH): 266, 364; (NaOMe): 274, 327sh, 401; (AlCl3): 274, 304, 349, 396; (AlCl3/HCl): 274, 345, 394; (NaOAc): 274, 305, 393; (NaOAc/H3BO3): 267, 352. 1H–NMR (400 MHz, DMSO–d6) δ 8.0 (2H, d, H–2'/6', J=8.5), δ 6.9 (2H, d, H–3'/5', J=8.5), δ 6.5 (1H, d, J=2 Hz, H–8), 6.2 δ (1H,d, J=2.5 Hz, H–6), 5.4 (1H,d,J=7.5, H–1''), 3.80–3.10 (5H,m,remaining sugar protons).

Myricetin 3–O–β–glucoside (7): 1H–NMR of (400 MHz, DMSO–d6) δ 7.16 (2H, s, H–2'/6'), δ 6.13(1H, d, J=2.5 Hz, H–6), 6.35 δ (1H,d, J=2.5 Hz, H–8), 5.45 (1H, d, J=7.55, H–1''), 3.90–3.20 (m, remaining sugar protons). 13C–NMR (100 MHz, DMSO–d6): δ ppm 177.85 (C–4), 164.83 (C–7), 161.71 (C–5), 156.81 (C–2), 156.71 (C–9), 146.49 (C–3'), 145.87 (C–5'), 137.97 (C–4'), 133.95 (C–3), 120.49 (C–1'), 109 (C–2',6'), 104.37 (C–10), 101.4 (C–1''), 99.22 (C–6), 93.00 (C–8), 78.04 (C–5''), 77.04 (C–3''), 74.44 (C–2''), 70.36(C–4'') 61.52 (C–6'').

Quercetin 3–O–rutinoside (Rutin) (8): 1H–NMR (400 MHz, DMSO–d6): δ ppm 7.54 (2H, m H–2'/6'), 6.85 (1H, d, J=9 Hz, H–5'), 6.38 (1H, d, J=2.5Hz, H–8), 6.19 (1H,J=2.5Hz, H–6), 5.35 (1H, d, J=7.5 Hz, H–1''), 5.33 (1H, br s, OH), 5.02,(2H each, br s, OH groups), 4.39 (1H, s, H–1'''), 3.90–3.20 (m, remaining sugar protons), 0.99 (3H, d, J=6 Hz, H–6'''). 13C NMR(100 MHz, DMSO–d6): δ ppm 177.85 (C–4), 164.70 (C–7), 161.68 (C–5), 157.14 (C–2), 156.95 (C–9), 148.92 (C–4'), 145.25 (C–3'), 133.76 (C–3), 122.12 (C–6'), 121.66 (C–1'), 116.73 (C–2'),115.72 (C–5'),104.41 (C–10), 101.66 (C–1'''), 101.23 (C–1''), 99.24 (C–6), 94.16 (C–8), 74.58(C–3''),72.33(C–5''), 72.2 (C–4'''), 71.05(C–2''), 70.8(C–2'''), 70.87(C–3''') 70.49(C–4'') 68.74 (C–6'') 18.19(C–6''').

Antimicrobial activity of B. racemosa extract

For the antimicrobial qualitative methods, i.e. paper filter disks impregnated with the tested extract solution and disposal of the respective solutions in agar wells, the reading of the results was performed by measuring the microbial growth inhibition zones around the filter disks impregnated with the testing extract and around the wells, respectively. The most efficient qualitative method proved to be the direct spotting of the tested solutions on the seeded medium, the results being very well correlated with the results of the (minimal inhibitory concentration) MIC quantitative assay. For the quantitative methods of the antimicrobial activity of the tested extract by the microdilution method in liquid medium, the MIC was read by wells observation: in the first wells containing high concentrations of extract, the culture growth was not visible, the microbial cells being killed or inhibited by the tested extract. At lower concentrations of the tested extract, the microbial culture becomes visible. The lowest concentration which inhibited the visible microbial growth was considered the MIC (μg/mL) value for the extract. In the next wells, including the standard culture growth control wells, the medium become muddy as a result of the microbial growth. In the sterility control wells series, the medium had to remain clear. From the last well without any visible microbial growth and from the first one that presented microbial growth, Gram stained smears were performed for the results confirmation. In Table 1, there are the results of the quantitative assay of the antimicrobial activity of the B. racemosa extract. Our results have shown that the extract was highly active against C. albicans, suggesting its possible use in the treatment of fungal infections, also it exhibited antimicrobial activity on B. subtilis and it has shown a moderate antimicrobial activity against K. pneumoniae but it was not active on other bacterial strains.

Antioxidant activity B. racemosa and Total polyphenol content

Antioxidant activity was evaluated by Oxygen Radical Absorbance Capacity (ORAC) and Trolox equivalent antioxidant capacity method (TEAC) assays. In (TEAC) assay, B. racemosa extract showed high TEAC value 201 ± 3.6 mM TE/g (Table 2), as well as it showed a high total polyphenol content 695.1 ± 3.56 mg/g (Table 2) which was expressed as gallic acid equivalents, while in ORAC assay, B. racemosa extract has shown lower ORAC value (1033 mM TE/g) (Table 2) these results suggest the antioxidant activity of B. racemosa and the high content of polyphenols in the methanol extract of B. racemosa is in agreement with phytochemical analysis of the extract which has shown the presence of flavonoids, tannins, coumarins (phenolic components), alkaloids and carbohydrates (Table 3). Phenolic compounds form one of the main classes of secondary metabolites. They display a large range of chemical structures and are responsible for the major bioactivity of plants. Flavonoids have shown a significant antimicrobial activity (32, 33), tannins have shown a significant antimicrobial and antioxidant activities (34), as well as coumarins have shown a good antimicrobial and antioxidant effects (35).

Chemical and Chromatographic separations of B. racemosa methanol extract yielded eight known phenolic compounds which were isolated and purified by standard methods. Compounds 1, 2 were white amorphous powder, showed chromatographic properties and colour reactions (positive FeCl3 and KIO3 tests) indicative of galloyl esters (36). Compounds 3, 4 detected as yellow spots on PC under UV light did not change by ammonia vapour. While compounds 5, 6, 7 and 8 appeared as dark purple spots under UV light, change to yellow when fumed to ammonia. The chemical investigation of compounds 5, 6, 7 and 8 was followed by paper chromatography to identify the hydrolytic flavonoid–O–glycoside products whether aglycone and sugar moieties. The identification of the isolated compounds was confirmed by co–chromatography with authentic samples, UV and NMR spectroscopy and MS spectrometry. The spectral data of the isolated compounds were compared with the literature data (37-39). On the basis from above, it can be concluded that B. racemosa methanol extract has significant antimicrobial activity and possess better antioxidant activity and these activities are due to the high polyphenol content and the interesting bioactive compounds include flavonoids (kaempferol, quercetin, querection–3–O–α–rhamnoside, kaempferol–3–O–β–glucoside, myricetin–3–O–β–glucoside and querection–3–O–rutinoside) and tannins (methyl gallate and gallic acid).

References

  • 1.

    Lopez A, Hudson JB, Towers GHN. Antiviral and antimicrobial activities of Colombian medicinal plants. J. Ethnopharmacol. 2001;77:189-196. [PubMed ID: 11535363].

  • 2.

    De Groot H, Mulder WM, Terreehorst I. Utility of desensitisation for allergy to antibiotics. Neth. J. Med. 2012;70:58-62. [PubMed ID: 22418750].

  • 3.

    Davis J. Inactivation of the antibiotics and the dissemination of resistance genes. Sci. 1994;264:375-382.

  • 4.

    Jain A. Extra pulmonary tuberculosis: a diagnostic dilemma, Ind. J. Clin. Biochem. 2011;26:269-273.

  • 5.

    Farnsworth NR. Biological and Phytochemical screening of plants. J. Pharma. Sci. 1966;55:225-276.

  • 6.

    Afolayan AJ, Meyer JJM. Antimicrobial activity of 3,5,7–trihydroxy flavone isolated from the shoots of Helichrysum aureonitens. J. Ethnopharmacol. 1997;57:177-181. [PubMed ID: 9292410].

  • 7.

    Bueno J, Coy ED, Stashenko E. Antimycobacterial natural products-an opportunity for the Colombian biodiversity. Rev. Esp. Quimioter. 2011;24:175-183. [PubMed ID: 22173186].

  • 8.

    Scholar P. Natural antioxidant exploited commercially In BJF Hudson. Food Antioxid. 1990;99:170-176.

  • 9.

    Kim SN, Kim MR, Cho SM, Kim SY, Kim JB, Cho YS. Antioxidant activities and determination of phenolic compounds isolated from oriental plums (Soldam, Oishiwase and Formosa). Nutr. Res. Pract. 2012;6:277-285. [PubMed ID: 22977680].

  • 10.

    Granner DK. Insulin oral Hypoglycemic Agents and the pharmacology of Endocrine Pancreas. New York: Mcgraw–Hill; 1996. p. 1487-1518.

  • 11.

    Kumar RS, Sivakumar T, Sunderam RS, Gupta M, Mazumdar UK, Gomathi P, Rajeshwar Y, Saravanan S, Kumar MS, Murugesh K, Kumar KA. Antioxidant and antimicrobial activities of Bauhinia racemosa L. stem bark. Braz. J. Med. Biol. Res. 2005;38:1015-1024.

  • 12.

    Bailey CJ, Day C. Traditional plant medicines as treatment for diabetes. Diabetes Care. 1989;12:13-29.

  • 13.

    Nirmal S, Laware R, Rathi RA, Dhasade V, Kuchekar B. Antihistaminic effect of Bauhinia racemosa leaves. J. Young Pharmists. 2011;3:129-131.

  • 14.

    Prakash A, Khosa RL. Chemical studies on Bauhinia racemosa. Curr. Sci. 1976;45:705-707.

  • 15.

    Kumar RS, Sunderam RS, Sivakumar T, Sivakumar P, Sureshkumar R, Kanagasabi R, Vijaya M, Perumal BP, Gupta M, Mazumdar UK, Kumar MS, Kumar KA. Effect of Bauhinia racemosa stem bark on N–nitrosodiethylamine-induced hepatocarcinogenesis in rats. Am. J. Chin. Med. 2007;35:103-114. [PubMed ID: 17265555].

  • 16.

    El–Hossary GA, Selim MA, Sayed AE, Khaleel AE. Study of the flavonoid content of Bassia muricata and Bauhinia recemosa. Bull. Fac. Pharm. Cairo Univ. 2000;38:93.

  • 17.

    Anjaneyulu ASR, Reddy AVR, Reddy DSK, Ward RS, Adhikesavalu D, Cameron TS. A new dibenzo (2,3–6,7) oxepin derivative from Bauhinia racemosa. Tetrahed. 1984;40:4245-4252.

  • 18.

    El–khatiba AS, Khaleel AE. Evalution of some pharmacological properties of different extracts of Bauhinia recemosa leaf and Bassia nuricata whole plant. Bull. Fac. Pharm. Cairo Univ. 1995;33:59-65.

  • 19.

    Gupta M, Mazumder UK, Kumar RS, Gomathi P, Rajeshwar Y, Kakoti BB, Selven VT. Anti-inflammatory, analgesic and antipyretic effects of methanol extract from Bauhinia racemosa stem bark in animal models. J. Ethnopharmacol. 2005;98:267-273. [PubMed ID: 15814258].

  • 20.

    Ali MS, Azhar I, Amtul Z, Ahmad VU, Usmanghani K. Antimicrobial Screening of Some Caesalpiniaceae. Fitoterapia. 1995;70:299-304.

  • 21.

    Akhtar AH, Ahmad KU. Anti–ulcerogenic evaluation of the methanol extract of some indigenous medicinal plants of Pakistan in aspirin ulcerated rats. J. Ethnopharmacol. 1995;46:1-6. [PubMed ID: 7475118].

  • 22.

    Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Roy C. Screening of Indian plants for biological activity. Ind. J. Exp. Biol. 1968;6:232-247.

  • 23.

    Kumar RS, Gupta M, Mazumdar UK, Rajeshwar Y, Kumar TS, Gomathi P, Roy R. Effects of methanol extracts of Caesalpinia bonducella and Bauhinia racemosa on hematology and hepatorenal function in mice. J. Toxicol. Sci. 2005;30:265-274. [PubMed ID: 16404135].

  • 24.

    Petra L, Edda B, Elke G, Jutta W, Helmut H. Comparsion of Broth Microdilution, E test, and Agar Dilution Methods for Antibiotic Susceptibility Testing Camplylobacter Jejuni and Camplylobacter. Coli. J. Clin. Microbiol. 2003;41:1062-1068.

  • 25.

    Bagiu RV, Vlaicu B, Butnariu M. Chemical composition and in-vitro antifungal activity screening of the Allium ursinum L (Liliaceae). Int. J. Molecul. Sci. 2012;13:1426-1436.

  • 26.

    Das K, Tiwari RKS, Shrivastava DK. Techniques for evalauation of medicinal plant products as antimicrobial agent: Current methods and future trends. J. Med. Plants Res. 2010;4:104-111.

  • 27.

    Zuo GY, An J, Han J, Zhang YL, Wang GC, Hao XY, Bian ZQ. Isojacareubin from the chinese herb hypericum japonicum: potent antibacterial and synergistic effects on clinical methicillin-resistant staphylococcus aureus (MRSA). Int. J. Molecul. Sci. 2012;13:8210-8218.

  • 28.

    Folin O, Ciocalteu V. On tyrosine and tryptophan determination in proteins. J. Biol. Chem. 1927;73:627-650.

  • 29.

    Sofowra A. Medicinal Plants And traditional Medicine in Africa. Ibadan, Nigeria: Spectrum Books Ltd; 1993. p. 191-289.

  • 30.

    Trease GE, Evans WC. Pharmacology. 11th ed. Bailliere Tindall, London; 1989. p. 45-50.

  • 31.

    Harborne JB. Phytochemical Methods. London: Chapman and Hall. Ltd; 1973. p. 49-188.

  • 32.

    Lamb AJ, Cushnie Tim TP. Antimicrobial activity of flavonoids. Int. J. Antimicrobial Agents. 2005;26:343-356.

  • 33.

    Tapas AR, Sakarkar DM, Kakde RB. Flavonoids as Nutraceuticals: A review. Tropical J. Pharm. Res. 2008;7:1089-1099.

  • 34.

    Reddy MK, Gupta SK, Jacob MR, Khan SI, Ferreira D. Antioxidant, antimalarial and antimicrobial activities of tannin–rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med. 2007;3:461-467. [PubMed ID: 17566148].

  • 35.

    Adriana B, Sergio S, Vivienne S, Maurizio B, Antonella M, Nicoletta F, Sergio R. Antimicrobial and antioxidant activities of coumarins from the roots of ferulago campestris (Apiaceae). Molecules. 2009;14:939-952. [PubMed ID: 19255552].

  • 36.

    Foo LY. Amarin, a di–dehydrohexahydroxydiphenol hydrolysable tannin from Phyllantus amarus. Phytochem. 1993;33:487-491.

  • 37.

    Markham KR. Techniques of Flavonoid Identification. London: Academic Press; 1982. p. 99-186.

  • 38.

    Mabry TJ, Markham KR, Thomas MB. The Systematic Identification of Flavonoids. Berlin: Springer– Verlag; 1970. p. 292-309.

  • 39.

    Harborne JB, Mabry TJ. The Flavonoids: Advances in Research. London. New York: Chapman and Hall; 1982. p. 24-132.